REMS programs. Megamergers. Generic encroachment. New sampling guidelines. The “unknowns” in the pharma industry have never been more prevalent or complex. But despite volumes of lagging prescription data and recall-based market research, pharma is still struggling to understand and anticipate how each new industry issue will impact current and future success. The key to understanding…
This past September, Med Ad News began its now-annual search for the future of pharmaceutical marketing. We sought out young companies to profile that are providing the most innovative and interesting products, services, or marketing opportunities to pharmaceutical companies and the healthcare community. After reviewing dozens of nominations, many of which were provided by our…
Just a few short years ago most doctors were technophobic. You would have been hard-pressed to get a physician to consider electronic prescribing or logging-on to web-based medical conference. What a difference a few years can make. According to Manhattan Research, in 2009 ,87% of US physicians are considered “ePharma” physicians. In others words, they…
In the upcoming November issue of Med Ad News, our sales-force effectiveness series continues with a technology round up, providing a catalogue of new and upgraded tech solutions for pharma sales forces. But technology is not only connecting healthcare professionals with pharmaceutical marketers. Physicians are connecting with their patients through digital channels as well. According…
It doesn’t take several years of post-graduate studies and a degree in medicine to describe what it’s like to live with a disease. From a patient’s perspective, the practical wisdom available in an embar-rassing anecdote, or a triumphant description of a breakthrough,can sometimes provide more value than any discussion to be had inside a doctor’s…
WHO: Jeffrey Dierks, Senior Product Director, Endo Pharmaceuticals WHAT: “Adherence as part of a commercial strategy: How to create value through communication and co-ordination, leading to better relationships with patients” This presentation will include information that demonstrates how the analysis of real-life, in-office dialogue between patients and physicians is critical to revealing concrete and specific recommendations…
Do you know what your cancer drug is up to? Answering that question is not as simple as for medicines taken by well-defined patient groups, or principally for one disease. Yet among drug classes oncology treatments hold a unique position: A frightening disease of immense scientific interest, hundreds of pipeline drugs and nearly as many…
Generalized fears about taking medications are common among patients, according to a new study issued by Verilogue exploring the actual fears and concerns patients most frequently discuss in their doctors’ offices and how doctors respond to them. The review of 23,923 naturally occurring patient-doctor interactions across 14 specialties during the course of 18 months found…
The pharmaceutical sales force is undergoing a dra-matic evolution as the pharmaceutical industry shifts from pri-mary-care drugs to biotechnology and specialist medicines. To effectively promote this changing product mix, marketers must adapt their sales and marketing models. In particular, marketers need sales representatives with more clinical knowledge, patient focus, managed-care fluency, and understanding of territories.…
FDA is under new management. Margaret Hamburg, M.D., was sworn in to her position as FDA commissioner May 22, 2009, by Health and Human Services Secretary Kathleen Sebelius. Dr. Hamburg is an authority on global health,public health systems, infectious disease, bioterrorism, and emergency preparedness. She served as the Nuclear Threat Initiative’s founding VP for the…